Bavarian Nordic AS (CHIX:BAVAC) Cyclically Adjusted Revenue per Share: kr49.16 (As of Mar. 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
82 GF Score
Price kr188.30
GF Value kr158.89
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Cyclically Adjusted Revenue per Share?

Bavarian Nordic AS CHIX:BAVAC 82 Cyclically Adjusted Revenue per Share is kr49.16 as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 82/100 and a GF Value™ of kr158.89 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bavarian Nordic AS's adjusted revenue per share for the three months ended in Mar. 2026 was kr12.480. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr49.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bavarian Nordic AS's average Cyclically Adjusted Revenue Growth Rate was 12.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bavarian Nordic AS was 12.80% per year. The lowest was 2.00% per year. And the median was 9.10% per year.

As of today (2026-07-11), Bavarian Nordic AS's current stock price is kr188.30. Bavarian Nordic AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr49.16. Bavarian Nordic AS's Cyclically Adjusted PS Ratio of today is 3.83.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bavarian Nordic AS was 13.57. The lowest was 3.21. And the median was 5.56.


Bavarian Nordic AS  (CHIX:BAVAc) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bavarian Nordic AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=188.30/49.16
=3.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bavarian Nordic AS was 13.57. The lowest was 3.21. And the median was 5.56.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bavarian Nordic AS Cyclically Adjusted Revenue per Share Related Terms


Bavarian Nordic AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Cyclically Adjusted Revenue per Share Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.24 37.20 42.07 46.98

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.82 48.87 49.31 46.98 49.16

CHIX:BAVAC vs VRTX, REGN, ALNY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Cyclically Adjusted PS Ratio falls into.


CHIX:BAVAC
82GF Score
Bavarian Nordic AS CHIX:BAVAC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bavarian Nordic AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=12.48/121.6800*121.6800
=12.480

Current CPI (Mar. 2026) = 121.6800.

Bavarian Nordic AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.219 100.600 3.894
201609 11.705 100.200 14.214
201612 10.340 100.300 12.544
201703 5.169 101.200 6.215
201706 10.183 101.200 12.244
201709 18.192 101.800 21.745
201712 1.009 101.300 1.212
201803 0.279 101.700 0.334
201806 2.115 102.300 2.516
201809 5.530 102.400 6.571
201812 4.409 102.100 5.255
201903 3.947 102.900 4.667
201906 3.177 102.900 3.757
201909 4.504 102.900 5.326
201912 7.103 102.900 8.399
202003 8.947 103.300 10.539
202006 13.831 103.200 16.308
202009 10.598 103.500 12.460
202012 3.920 103.400 4.613
202103 9.000 104.300 10.500
202106 5.910 105.000 6.849
202109 7.162 105.800 8.237
202112 8.382 106.600 9.568
202203 4.590 109.900 5.082
202206 7.694 113.600 8.241
202209 16.577 116.400 17.329
202212 18.006 115.900 18.904
202303 16.966 117.300 17.600
202306 26.214 116.400 27.403
202309 17.778 117.400 18.426
202312 31.650 116.700 33.001
202403 10.897 118.400 11.199
202406 18.040 118.500 18.524
202409 17.407 118.900 17.814
202412 26.261 118.900 26.875
202503 16.620 120.200 16.825
202506 20.497 120.700 20.663
202509 22.501 121.600 22.516
202512 20.208 121.200 20.288
202603 12.480 121.680 12.480

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr49.16 mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Cyclically Adjusted Revenue per Share of kr49.16 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Cyclically Adjusted Revenue per Share too high?
Bavarian Nordic AS's current Cyclically Adjusted Revenue per Share is kr49.16. Overall, Bavarian Nordic AS has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Bavarian Nordic AS's Cyclically Adjusted Revenue per Share of kr49.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Cyclically Adjusted Revenue per Share is kr49.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr158.89, compared to a current price of kr188.30 — trading 18.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr49.16. Bavarian Nordic AS's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Cyclically Adjusted Revenue per Share is kr49.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 18.5% above its estimated GF Value™ of kr158.89. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for CHIX:BAVAC:

  • Cyclically Adjusted Revenue per Share: kr49.16
  • GF Value™: kr158.89 vs. price of kr188.30 (18.5% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
82GF Score

Get the complete analysis for CHIX:BAVAC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr158.89
GF Value